Abizer Gaslightwala's most recent trade in Akari Therapeutics Plc - ADR was a trade of 5,203 American Depositary Shares representing Ordinary Shares done at an average price of $1.2 . Disclosure was reported to the exchange on June 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.16 per share. | 23 Jun 2025 | 5,203 | 277,574 (0%) | 0% | 1.2 | 6,035 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.15 per share. | 23 Jun 2025 | 943 | 272,371 (0%) | 0% | 1.1 | 1,084 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 20 Jun 2025 | 10,000 | 271,428 (0%) | 0% | 1.2 | 12,000 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.20 per share. | 17 Jun 2025 | 15,000 | 261,428 (0%) | 0% | 1.2 | 18,000 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director, CEO | Grant, award, or other acquisition of securities at price $ 1.19 per share. | 12 Jun 2025 | 25,000 | 246,428 (0%) | 0% | 1.2 | 29,750 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director, CEO | Grant, award, or other acquisition of securities at price $ 1.23 per share. | 12 Jun 2025 | 20,000 | 221,428 (0%) | 0% | 1.2 | 24,600 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director, CEO | Grant, award, or other acquisition of securities at price $ 1.27 per share. | 10 Jun 2025 | 20,000 | 201,428 (0%) | 0% | 1.3 | 25,400 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 1,100,000 | 1,100,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 600,000 | 600,000 | - | - | Stock Option (Right to Buy) | |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 133,928 | 133,928 | - | - | Series A Warrants (Right to Buy) | |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 06 Mar 2025 | 133,928 | 181,428 (0%) | 0% | 1.1 | 149,999 | American Depositary Shares representing Ordinary Shares |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 133,928 | 133,928 | - | - | Series B Warrants (Right to Buy) | |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 1.22 per share. | 10 Jan 2025 | 11,640 | 47,500 (0%) | 0% | 1.2 | 14,201 | American Depository Shares representing Ordinary Shares |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 1.22 per share. | 10 Jan 2025 | 11,439 | 35,860 (0%) | 0% | 1.2 | 13,956 | American Depository Shares representing Ordinary Shares |
| Akari Therapeutics Plc - ADR | Abizer Gaslightwala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 1,720,000 | 71,720,000 (4%) | 0% | 0.0 | 1,032 | Ordinary Shares, par value $0.0001 per share |
| Akari Therapeutics Plc - ADR | Gaslightwala Abizer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2024 | 40,000,000 | 70,000,000 (4%) | 2% | 0.0 | 20,000 | Ordinary Shares, par value $0.0001 per share |
| Akari Therapeutics Plc - ADR | Gaslightwala Abizer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2024 | 30,000,000 | 30,000,000 (1%) | 1% | 0.0 | 15,000 | Ordinary Shares, par value $0.0001 per share |